Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Choosing sectors for retirement requires matching income needs with risk tolerance. This guide highlights practical picks to support steady retirement cash flow.
23,834 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
A sizable move in the First Trust QTEC fund has traders buzzing. Is the sale a warning sign for overheated AI stocks ...
Wingstop has slumped 60% in the last year amid a negative equity balance sheet. Meanwhile, three asset-heavy stocks—r...
The latest data show the average american savings rate falling to 2.6% in April, a sign of rising household stress. A...
As stocks climb, a warning from the former chair of the Federal Reserve signals risk ahead. This guide explains the t...
This in-depth piece dives into Chile's bold tax reform plan and what it could mean for growth, investment, and global...
Enrollment of international students fell sharply as policy shifts took hold, triggering sharp revenue declines for c...
The U.S. has removed foreign-access restrictions on Anthropic’s Claude 3.5 and Fable 5, signaling a renewed AI leader...
As Tesla fans cheer long-term robotaxi dreams, traders worry about delivery misses. A growing crowd is exploring inve...
The AI inference market could surge to about $255 billion by 2030 as demand for real-time AI services climbs. Learn w...
Cavco stock rose about 9% over the past year even as a large fund pulled roughly $12 million in Cavco shares. This ar...
From public housing in Brooklyn to Harvard at 16 and a 12-year Goldman Sachs tenure, the former Goldman Sachs leader ...